Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000630100 | SCV000751056 | likely benign | Hereditary nonpolyposis colorectal neoplasms | 2023-10-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001016596 | SCV001177562 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-10-04 | criteria provided, single submitter | clinical testing | The p.T928N variant (also known as c.2783C>A), located in coding exon 4 of the MSH6 gene, results from a C to A substitution at nucleotide position 2783. The threonine at codon 928 is replaced by asparagine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Gene |
RCV001756039 | SCV002006361 | uncertain significance | not provided | 2019-09-03 | criteria provided, single submitter | clinical testing | Not observed at a significant frequency in large population cohorts (Lek 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge |
Center for Genomic Medicine, |
RCV002465740 | SCV002760664 | uncertain significance | not specified | 2025-03-04 | criteria provided, single submitter | clinical testing |